The role of radiotherapy in the management of skin cancer is well established,' but the management of basal cell carcinoma of the eyelid is controversial. There is a reluctance among some ophthalmologists to refer patients for radiotherapy because of the fear of serious complications and a high failure rate. This is undoubtedly due to the calamities attendant on the use of radiotherapy in the early part of this century. An analysis of a series of 127 patients treated by a standard 5-day course of outpatient superficial radiotherapy reveals a 100% local control rate with a minimum 3-year follow-up. The minor complication rate was low and there were no serious complications. The Table 1 shows the regional distribution of the tumours and Table 2 the age distribution. Table  3 shows the size distribution of the lesions.
All our patients were treated with a standard fractionation regimen and each lesion was treated with a dose of 3400 cGy given in five consecutive daily fractions of680 cGy using a 90 keV beam. A minimum margin of 0-5 cm around the visible lesion was employed and the underlying eye was 
Complications
In 1948 Duke-Elder and Parsons stated that, for eyelid tumours, excision should be the rule and radiation the exception,5 however, by 1974 these views had profoundly altered and they considered6 that 'excision or radiotherapy are probably equally effective when efficiently carried out.' It is undoubtedly the fearofradiation complications that is the main reason for preferring surgery to radiation therapy. In our series complications of treatment have been minimal and are listed in Table 5 .
Moderate skin changes and epilation are viewed as equivalent to a surgical scar and are not considered as complications. Ectropion is often present before treatment and epiphora is frequently seen at presentation with lesions of the medial canthus. Two of our patients developed canalicular stenoses following treatment of lesions involving the lower punctum and canaliculus which would have required excision of these structures had surgery been undertaken. Mustarde78 has stated that in reconstructive surgery of the medial canthus it is possible to remove the lacrimal passages completely without epiphora, which is only likely to occur in the presence of conditions causing excessive tear formation such as a high wind, excessive exposure of the conjunctiva, and inflammatory conditions involving the lid margin, conjunctiva, cornea or lacrimal sac. Keratinisation of the Despite the above list of potential complications the results from radiotherapy are excellent both in terms of tumour control and cosmetic result as shown in Table 6 .
Prevention of complications
Patients who have an eyelid tumour irradiated invariably develop a radiation reaction in the treated area. While this reaction ultimately subsides the related bulbar conjunctiva and the cornea may be affected despite the presence of a lead contact lens during treatment. Antibiotic Figure 2 Acrylic coated lead internal eyeshield employed to protect the eye.
The treatment ofperiocular basal cell carcinomas by radiotherapy Table 7 records some of the major surgical series. In three of these frozen section control of the margins was undertaken adding considerably to the duration of the procedure. In Collin's series9 71 2% of patients had either a flap or a graft procedure, yet 96% of the lesions were Ti by stage and eminently suitable for local radiotherapy; Frank,'0 in her series employing frozen section control, used flaps or grafts in more than 50% ofcases. The results ofboth radiotherapeutic and surgical treatment are similar but, in view of the complexity of the surgical procedures that have to be employed even for small radiocurable tumours, we would submit that radiotherapy when performed with meticulous attention to the tumour margins and with every care taken to minimise morbidity is the treatment of choice for the majority of basal cell carcinomas of the eyelid, though surgery has an important role in the management of upper eyelid lesions and extensive tumours at the medial canthus whose deep margins may be assessable only at surgery. These tumours if they recur may spread deeply into the orbit and sinuses necessitating exenteration for cure. '4 The patients' interests are best safeguarded by ensuring close collaboration between ophthalmologists, plastic surgeons, radiotherapists, and dermatologists so that therapeutic approaches based on a partisan approach are avoided if possible. Each tumour must be judged on its merits and the most appropriate modality for each patient carefully decided.
Recurrence after previous radiotherapy should be treated surgically as the risk ofradiation necrosis is excessive. However Lafontan et al'5 16 using interstitial radiotherapy techniques have successfully treated radiation failures, but this technique is not readily available and requires considerable expertise. The rare lesion in the middle third of the upper eyelid constitutes a relative contraindication to radiation due to the probable risk of tarsal keratinisation and the risk of corneal damage and we do not routinely irradiate these lesions. However ifa lesion on the upper lid is sufficiently large to require an extensive plastic procedure then radiotherapy becomes an attractive alternative, as keratinisation does not invariably ensue and a contact lens may suffice to protect the cornea adequately. If the eyelid tumour is related to a damaged or abnormal cornea the risk of further damage to the cornea from irradiation changes in the eyelid should lead one to consider surgery as the favoured treatment. The advanced basal cell carcinoma with bone involvement is rarely eradicated by radiotherapy and is best treated by a course of radical radiotherapy followed by radical surgery.
Conclusion
Our data show meticulously planned superficial radiotherapy to be a highly effective treatment for periocular basal cell carcinoma with excellent control rates and minimal morbidity in often elderly patients. We do not dismiss surgery but regard surgery and radiotherapy as complementary modalities.
